535 related articles for article (PubMed ID: 8672093)
1. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
Rastogi N; Labrousse V; Goh KS
Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
[TBL] [Abstract][Full Text] [Related]
2. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis.
Fattorini L; Iona E; Ricci ML; Thoresen OF; Orrù G; Oggioni MR; Tortoli E; Piersimoni C; Chiaradonna P; Tronci M; Pozzi G; Orefici G
Microb Drug Resist; 1999; 5(4):265-70. PubMed ID: 10647084
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Jul; 40(7):1610-6. PubMed ID: 8807049
[TBL] [Abstract][Full Text] [Related]
4. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
Ceyhan İ; Vezir S
Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
[TBL] [Abstract][Full Text] [Related]
5. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Bhusal Y; Shiohira CM; Yamane N
Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
[TBL] [Abstract][Full Text] [Related]
6. Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.
Lu PL; Peng CF; Hwang JJ; Chen YH
J Chemother; 2008 Apr; 20(2):202-7. PubMed ID: 18467246
[TBL] [Abstract][Full Text] [Related]
7. Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis.
Rastogi N; Ross BC; Dwyer B; Goh KS; Clavel-Sérès S; Jeantils V; Cruaud P
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):901-7. PubMed ID: 1362540
[TBL] [Abstract][Full Text] [Related]
8. Antituberculosis activity of clarithromycin.
Luna-Herrera J; Reddy VM; Daneluzzi D; Gangadharam PR
Antimicrob Agents Chemother; 1995 Dec; 39(12):2692-5. PubMed ID: 8593004
[TBL] [Abstract][Full Text] [Related]
9. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Lu T; Drlica K
J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
[TBL] [Abstract][Full Text] [Related]
12. A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.
Wedajo W; Schön T; Bedru A; Kiros T; Hailu E; Mebrahtu T; Yamuah L; Ängeby K; Werngren J; Onyebujoh P; Dagne K; Aseffa A
BMC Res Notes; 2014 Aug; 7():512. PubMed ID: 25108648
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods].
Varıcı Balcı FK; Çavuşoğlu C
Mikrobiyol Bul; 2018 Apr; 52(2):123-134. PubMed ID: 29933730
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
Mor N; Esfandiari A
Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs.
Tomioka H; Sato K; Shimizu T; Sano C
J Infect; 2002 Apr; 44(3):160-5. PubMed ID: 12099742
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Huang CC; Wu MF; Chen HC; Huang WC
J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.
Cavalieri SJ; Biehle JR; Sanders WE
Antimicrob Agents Chemother; 1995 Jul; 39(7):1542-5. PubMed ID: 7492101
[TBL] [Abstract][Full Text] [Related]
19. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
20. Use of Whole-Genome Sequencing to Predict
Wu X; Tan G; Sha W; Liu H; Yang J; Guo Y; Shen X; Wu Z; Shen H; Yu F
Microbiol Spectr; 2022 Apr; 10(2):e0251621. PubMed ID: 35311541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
